Frank M. Torti

Malecare Provides Comments to Dr. Torti, the new Acting Director of the FDA

Last Friday's post included information about the recent appointment of Dr. Frank M. Torti as the Acting Director of the FDA. Dr. Torti has invited public comments about the future direction of the FDA. As a representative of Malecare, I have provided specific feedback to Dr. Torti. The following post includes my comments to him. [...]

By Malecare|2017-10-19T10:56:22-04:00January 26th, 2009|Advanced Prostate Cancer, Advocacy, FDA, Provenge, Satraplatin, Uncategorized|0 Comments

Dr. Torti Appointed Acting Director of the FDA

Dr. Frank M. Torti, M.D., MPH has just been appointed as the Acting Commissioner of Food and Drugs (FDA). He has been a prominent clinician, scientist and researcher in molecular oncology. Until his appointment at the FDA as Principal Deputy Commissioner and first Chief Scientist in April 2008, Dr. Torti had served the as Charles [...]

By Malecare|2021-02-17T10:45:07-05:00January 23rd, 2009|Advanced Prostate Cancer, Advocacy, FDA, Politics of Cancer, Uncategorized|0 Comments